Paper33005239
Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects.
Kyohara M and 7 others. Diabetol Metab Syndr, 2020. Cited by 17 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects. Papers, record 33005239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33005239
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 82,604 | Mechanism of action of factor D of the alternative complement pathway. | J Exp Med | 1978 | https://conductscience.org/library/papers/82604 | PubMed |
| 2 | 30,746,502 | Association Between Serum Adipsin Levels and Insulin Resistance in Subjects With Various Degrees of Glucose Intolerance. | J Endocr Soc | 2019 | https://conductscience.org/library/papers/30746502 | PubMed |
| 3 | 19,181,734 | Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. | Clin Chem | 2009 | https://conductscience.org/library/papers/19181734 | PubMed |
| 4 | 19,919,682 | BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. | Genome Biol | 2009 | https://conductscience.org/library/papers/19919682 | PubMed |
| 5 | 20,809,771 | Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. | Scand J Gastroenterol | 2011 | https://conductscience.org/library/papers/20809771 | PubMed |
| 6 | 8,608,603 | Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. | Cell | 1996 | https://conductscience.org/library/papers/8608603 | PubMed |
| 7 | 12,582,019 | Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. | Cancer Epidemiol Biomarkers Prev | 2003 | https://conductscience.org/library/papers/12582019 | PubMed |
| 8 | 27,434,652 | Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome. | Clin Endocrinol (Oxf) | 2016 | https://conductscience.org/library/papers/27434652 | PubMed |
| 9 | 16,729,309 | Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. | Hepatology | 2006 | https://conductscience.org/library/papers/16729309 | PubMed |
| 10 | 31,700,183 | Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans. | Nat Med | 2019 | https://conductscience.org/library/papers/31700183 | PubMed |
| 11 | 29,432,659 | Relationship between serum adipsin and the first phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance. | J Diabetes Investig | 2018 | https://conductscience.org/library/papers/29432659 | PubMed |
| 12 | 20,032,566 | Body mass index, fasting plasma glucose levels, and C-peptide levels as predictors of the future insulin use in Japanese type 2 diabetic patients. | Endocr J | 2010 | https://conductscience.org/library/papers/20032566 | PubMed |
| 13 | 30,541,001 | Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study. | Ann Nutr Metab | 2019 | https://conductscience.org/library/papers/30541001 | PubMed |
| 14 | 28,868,790 | Insulin regulation of gluconeogenesis. | Ann N Y Acad Sci | 2018 | https://conductscience.org/library/papers/28868790 | PubMed |
| 15 | 27,246,738 | Adipocyte insulin receptor activity maintains adipose tissue mass and lifespan. | Biochem Biophys Res Commun | 2016 | https://conductscience.org/library/papers/27246738 | PubMed |
| 16 | 24,843,435 | Report of the committee on the classification and diagnostic criteria of diabetes mellitus. | J Diabetes Investig | 2010 | https://conductscience.org/library/papers/24843435 | PubMed |
| 17 | 20,339,361 | Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. | Obesity (Silver Spring) | 2010 | https://conductscience.org/library/papers/20339361 | PubMed |
| 18 | 24,995,977 | Adipsin is an adipokine that improves β cell function in diabetes. | Cell | 2014 | https://conductscience.org/library/papers/24995977 | PubMed |
| 19 | 26,149,458 | Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer. | J Transl Med | 2015 | https://conductscience.org/library/papers/26149458 | PubMed |
| 20 | 1,612,197 | Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. | Diabetes | 1992 | https://conductscience.org/library/papers/1612197 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,850,593 | Glucose-dependent regulation of hepatic adipsin controls glucose uptake and tolerance. | Mol Med | 2026 | https://conductscience.org/library/papers/42850593 | PubMed |
| 42,398,653 | Metabolite-driven remodeling of hepatic lipid metabolism by the plasticizer di-isononyl phthalate. | Mol Metab | 2026 | https://conductscience.org/library/papers/42398653 | PubMed |
| 40,196,377 | Interplay Between Insulin Resistance and Immune Dysregulation in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions. | Immunotargets Ther | 2025 | https://conductscience.org/library/papers/40196377 | PubMed |
| 40,072,105 | A Cross-Sectional Exploratory Study of Rat Sarcoid (Ras) Activation in Women with and Without Polycystic Ovary Syndrome. | Cells | 2025 | https://conductscience.org/library/papers/40072105 | PubMed |
| 39,682,799 | Capsaicin and Quercitrin Maintained Lipid Homeostasis of Hyperlipidemic Mice: Serum Metabolomics and Signaling Pathways. | Foods | 2024 | https://conductscience.org/library/papers/39682799 | PubMed |
| 38,202,116 | An Overview of Growth Factors as the Potential Link between Psoriasis and Metabolic Syndrome. | J Clin Med | 2023 | https://conductscience.org/library/papers/38202116 | PubMed |
| 37,996,895 | Exploring the underlying mechanisms of fisetin in the treatment of hepatic insulin resistance via network pharmacology and in vitro validation. | Nutr Metab (Lond) | 2023 | https://conductscience.org/library/papers/37996895 | PubMed |
| 35,956,419 | Therapeutic Role of Curcumin in Diabetes: An Analysis Based on Bioinformatic Findings. | Nutrients | 2022 | https://conductscience.org/library/papers/35956419 | PubMed |
| 35,648,976 | Reviewing physical exercise in non-obese diabetic Goto-Kakizaki rats. | Braz J Med Biol Res | 2022 | https://conductscience.org/library/papers/35648976 | PubMed |
| 35,037,854 | A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease. | Elife | 2022 | https://conductscience.org/library/papers/35037854 | PubMed |
| 33,537,089 | Organ-organ communication: The liver's perspective. | Theranostics | 2021 | https://conductscience.org/library/papers/33537089 | PubMed |
| 33,217,980 | Bioinformatic Reconstruction and Analysis of Gene Networks Related to Glucose Variability in Diabetes and Its Complications. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33217980 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADIPOQ | 9,370 | PubTator's text mining | https://conductscience.org/library/genes/9370 | NCBI Gene |
| CDH11 | 1,009 | PubTator's text mining | https://conductscience.org/library/genes/1009 | NCBI Gene |
| CFD | 1,675 | PubTator's text mining | https://conductscience.org/library/genes/1675 | NCBI Gene |
| EGFR | 1,956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| LEP | 3,952 | PubTator's text mining | https://conductscience.org/library/genes/3952 | NCBI Gene |
| LEPR | 3,953 | PubTator's text mining | https://conductscience.org/library/genes/3953 | NCBI Gene |
| POTEF | 728,378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| SELENOP | 6,414 | PubTator's text mining | https://conductscience.org/library/genes/6414 | NCBI Gene |
| SLC17A5 | 26,503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33005239
GET https://conductscience.org/api/papers/v1/33005239/references?page=2